Li Zhang
Shanghai Normal University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Head and Neck Cancer Studies, Cancer Treatment and Pharmacology, Lung Cancer Research Studies, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy(2014)382 cited
- → Pharmacogenetics and Pharmacogenomics: a Bridge to Individualized Cancer Therapy(2013)107 cited
- → A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer(2014)48 cited
- → Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment(2016)42 cited
- → FOXM1 Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non–Small Cell Lung Cancer(2022)40 cited
- → Prevalence of Burnout and Career Satisfaction Among Oncologists in China: A National Survey(2018)33 cited
- → Mendelian randomization study showed no causality between metformin use and lung cancer risk(2019)25 cited
- → Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy(2016)23 cited
- → Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations(2024)23 cited
- → Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma(2016)19 cited